NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

Molecular and Cellular Biology

Volumn 21, Issue 12, 2001, Pages 3964-3973

  Kreuz, Sebastian ^a   Siegmund, Daniela ^a   Scheurich, Peter ^a   Wajant, Harald ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 8; CYCLOHEXIMIDE; FLICE INHIBITORY PROTEIN; GELDANAMYCIN; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; BENZOQUINONE DERIVATIVE; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CARRIER PROTEIN; CD40 ANTIGEN; CFLAR PROTEIN, HUMAN; DNA BINDING PROTEIN; I KAPPA B; INTERLEUKIN 1; LEUPEPTIN; MACROCYCLIC LACTAM; MONOCLONAL ANTIBODY; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; QUINONE DERIVATIVE; SIGNAL PEPTIDE; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL LINE; GENETICS; HELA CELL; IMMUNOLOGY; METABOLISM; MUTATION; PHYSIOLOGY; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; APOPTOSIS; BENZOQUINONES; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LACTAMS, MACROCYCLIC; LEUPEPTINS; MUTATION; NF-KAPPA B; QUINONES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034744033     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.12.3964-3973.2001     Document Type: Article

References (45)

1. Barkett, M., D. Xue, H. R. Horvitz, and T. D. Gilmore. 1997. Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272:29419-29422.
2. Beauparlant, P., H. Kwon, M. Clarke, R. Lin, N. Sonenberg, M. Wainberg, and J. Hiscott. 1996. Transdominant mutants of IκBα block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J. Virol. 70:5777-5785.
3. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kappa B. Nature 376:167-170.
4. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784.
5. Chan, F. K.-M., and M. J. Lenardo. 2000. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 30:652-660.
6. Chan, H., D. P. Bartos, and L. B. Owen-Schaub. 1999. Activation-dependent transcriptional regulation of the human fas promoter requires NF-κB p50-p65 recruitment. Mol. Cell. Biol. 19:2098-2108.
7. L. Mol. Cell. Biol. 20:2687-2695.
8. Chu, Z.-L., T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA 94:10057-10062.
9. Goltsev, Y. V., A. V. Kovalenko, E. Arnold, E. E. Varfolomeev, V. M. Brodianskii, and D. Wallach. 1997. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:19641-19644.
10. Han, D. K., P. M. Chaudhary, M. E. Wright, C. Friedman, B. J. Trask, R. T. Riedel, D. G. Baskin, S. M. Schwartz, and L. Hood. 1997. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. USA 94:11333-11338.
11. Harhaj, E. W., L. Good, G. Xiao, M. Uhlik, M. E. Cvijic, I. Rivera-Walsh, and S.-C. Sun. 2000. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 19:1448-1456.
12. Hess, S., E. Gottfried, H. Smola, U. Grunwald, M. Schuchmann, and H. Engelmann. 1998. CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. Eur. J. Immunol. 28:3594-3604.
13. Hu, S., C. Vincenz, J. Ni, R. Gentz, and V. M. Dixit. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J. Biol. Chem. 272:17255-17257.
14. Inohara, N., T. Koseki, Y. Hu, S. Chen, and G. Nunez. 1997. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94:10717-10722.
15. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schroter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
16. Irmler, M., F. Martinon, N. Holler, V. Steiner, C. Ruegg, H. Wajant, and J. Tschopp. 2000. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett. 468:129-133.
17. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1:543-551.
18. Kelliher, M. A., S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger, and P. Leder. 1998. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297-303.
19. Kothny-Wilkes, G., D. Kulms, B. Pöppelmann, T. A. Luger, M. Kubin, and T. Schwarz. 1998. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 273: 29247-29253.
20. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136-9141.
21. Lee, M. P., and A. P. Feinberg. 1998. Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res. 58:1052-1056.
22. Levkau, B., M. Scatena, C. M. Giachelli, R. R. Ross, and E. W. Raines. 1999. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat. Cell Biol. 1:227-233.
23. Lewis, J., A. Devin, A. Miller, Y. Lin, Y. Rodriguez, L. Neckers, and Z. G. Liu. 2000. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J. Biol. Chem. 275:10519-10526.
24. Lin, Y., A. Devin, Y. Rodriguez, and Z. Liu. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13:2514-2526.
25. Liu, Z. G., H. L. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
26. Mühlenbeck, F., P. Schneider, J.-L. Bodmer, R. Schwenzer, A. Hauser, Schubert, P. Scheurich, D. Moosmayer, J. Tschopp, and H. Wajant. 2000. The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation. J. Biol. Chem. 275:32208-32213.
27. Park, C. G., S. Y. Lee, G. Kandala, S. Y. Lee, and Y. Choi. 1996. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 4:583-591.
28. Pimentel-Muinos, F. X., and B. Seed. 1999. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11:783-793.
29. Rasper, D. M., J. P. Vaillancourt, S. Hadano, V. M. Houtzager, I. Seiden, S. L. Keen, P. Tawa, S. Xanthoudakis, J. Nasir, D. Martindale, B. F. Koop, E. P. Peterson, N. A. Thornberry, J. Huang, D. P. MacPherson, S. C. Black, F. Hornung, M. J. Lenardo, M. R. Hayden, S. Roy, and D. W. Nicholson. 1998. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell. Death Differ. 5:271-288.
30. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319-329.
31. Reuther, J. Y., and A. S. Baldwin. 1999. Apoptosis promotes a caspase-induced amino-terminal truncation of IκBα that functions as a stable inhibitor of NF-κB. J. Biol. Chem. 274:20664-20670.
32. Roy, N., Q. L. Deveraux, R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914-6925.
33. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343-12346.
34. Srinivasula, S. M., M. Ahmad, S. Ottilie, F. Bullrich, S. Banks, Y. Wang, T. Fernandes-Alnemri, C. M. Croce, G. Litwack, K. J. Tomaselli, R. C. Armstrong, and E. S. Alnemri. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272:18542-18545.
35. Schwenzer, R., K. Siemienski, S. Liptay, G. Schubert, N. Peters, P. Scheurich, R. Schmid, and H. Wajant. 1999. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase. J. Biol. Chem. 274:19368-19374.
36. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789.
37. Wajant, H., E. Haas, R. Schwenzer, F. Mühlenbeck, S. Kreuz, G. Schubert, M. Grell, C. Smith, and P. Scheurich. 2000. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J. Biol. Chem. 275:24357-24366.
38. Walczak, H., and P. H. Krammer. 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256:58-66.
39. Wang, C. Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784-787.
40. Wang, C.-Y., M. V. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase-8 activation. Science 281:1680-1683.
41. Wang, J., A. A. Lobito, F. Shen, F. Hornung, A. Winoto, and M. J. Lenardo. 2000. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J. Immunol. 30:155-163.
42. Weiss, T., M. Grell, K. Siemienski, H. Dürkop, K. Pfizenmaier, P. Scheurich, and H. Wajant. 1998. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TRAF2 and is specific for TNFR60. J. Immunol. 161:3136-3142.
43. Wu, M., H. Y. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. Fitzgerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB /Rel induces apoptosis of murine B cells. EMBO J. 15:4682-4690.
44. Wu, M. X., Z. Ao, K. V. S. Prasad, R. Wu, and S. F. Schlossman. 1998. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281:998-1001.
45. Zong, W.-X., L. C. Edelstein, C. Chen, J. Bash, and C. Gélinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13:382-387.